ArticleScientific reports2022

Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells.

Oxana V Denisova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.